Company Profiles

driven by the PitchBook Platform

Athera Biotechnologies

Description

Developer of targeted anti-inflammatory drugs designed to create value by developing innovations from science into products that can be sold or out-licensed with high returns. The company's anti-inflammatory drug is used for the prevention and treatment of cardiovascular disease with proprietary clinical development stage program, enabling patients to lead a healthy life.

2005

Founded

PRIVATE

Status

1-10

Employees

2ndary - Private

Latest Deal Type

$2.82M

Latest Deal Amount

3

Investors

Description

Developer of targeted anti-inflammatory drugs designed to create value by developing innovations from science into products that can be sold or out-licensed with high returns. The company's anti-inflammatory drug is used for the prevention and treatment of cardiovascular disease with proprietary clinical development stage program, enabling patients to lead a healthy life.

Website:

www.athera.se

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Sankt Eriksgatan 117 4th Floor 113 43 StockholmSweden +46 (0)7 619 38 190
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Athera Biotechnologies's full profile, request a free trial.

Athera Biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Athera Biotechnologies Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
IndustrifondenVenture CapitalMinority000 0000000 0000
Linc InvestOtherMinority000 0000000 0000
ÖstersjöstiftelsenOtherMinority000 0000000 0000
Industrifonden Venture Capital
Linc Invest Other
Östersjöstiftelsen Other

Athera Biotechnologies Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Carina SchmidtChief Executive Officer
Anders Bergman Ph.DVice President IP and Legal
Knut Pettersson Ph.DVice President, Preclinical development
Tommy AbrahamssonSenior Advisor CVD Pharmaceuticals
Carina Schmidt Chief Executive Officer
Anders Bergman Ph.D Vice President IP and Legal
Knut Pettersson Ph.D Vice President, Preclinical development
Tommy Abrahamsson Senior Advisor CVD Pharmaceuticals

Athera Biotechnologies Board Members (3)

NameRepresentingRoleSinceContact
Info
Gunnar Olsson Ph.DSelfChairman of the Board000 0000
Jonas Brambeck Ph.DIndustrifondenInvestment Manager Life Science000 0000
Svein Arild MathisenSelfBoard Member000 0000
Gunnar Olsson Ph.D Chairman of the Board Self
Jonas Brambeck Ph.D Investment Manager Life Science Industrifonden
Svein Arild Mathisen Board Member Self
Request full access to PitchBook